These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 25238885)

  • 41. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.
    Firoozi S; Elliott PM; Sharma S; Murday A; Brecker SJ; Hamid MS; Sachdev B; Thaman R; McKenna WJ
    Eur Heart J; 2002 Oct; 23(20):1617-24. PubMed ID: 12323162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy.
    Meng X; Liang M; Shi Y; Zhang W; Zhou S; Gao C
    Anatol J Cardiol; 2020 Jun; 23(6):342-348. PubMed ID: 32478684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Prasad M; Geske JB; Sorajja P; Ommen SR; Schaff HV; Gersh BJ; Nishimura RA
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):962-970. PubMed ID: 27062082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results.
    Heric B; Lytle BW; Miller DP; Rosenkranz ER; Lever HM; Cosgrove DM
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):195-206; discussion 206-8. PubMed ID: 7609544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.
    Maron BJ; Yacoub M; Dearani JA
    Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z; Wang F; Dou X; Zhang S; Pu J
    Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA; Liebregts M; Steggerda RC; Schinkel AF; Willems R; Ten Cate FJ; van Cleemput J; Ten Berg JM; Michels M
    JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
    Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative left ventricular longitudinal strain predicts outcome of septal myectomy for obstructive hypertrophic cardiomyopathy.
    Cui H; Schaff HV; Nishimura RA; Geske JB; Dearani JA; Newman DB; Ommen SR
    J Thorac Cardiovasc Surg; 2023 Aug; 166(2):492-500.e2. PubMed ID: 34763894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-Centre Experience of Surgical Myectomy for Hypertrophic Obstructive Cardiomyopathy.
    Afanasyev AV; Bogachev-Prokophiev AV; Ovcharov MA; Pivkin AN; Zalesov AS; Budagaev SA; Sharifulin RM; Zheleznev SI; Karaskov AM
    Heart Lung Circ; 2020 Jun; 29(6):949-955. PubMed ID: 31427226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard.
    Brown ML; Schaff HV
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
    Woo A; Williams WG; Choi R; Wigle ED; Rozenblyum E; Fedwick K; Siu S; Ralph-Edwards A; Rakowski H
    Circulation; 2005 Apr; 111(16):2033-41. PubMed ID: 15824202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Collis R; Watkinson O; O'Mahony C; Guttmann OP; Pantazis A; Tome-Esteban M; Tsang V; Chandrasekaran V; McGregor CGA; Elliott PM
    Eur J Heart Fail; 2018 Feb; 20(2):398-405. PubMed ID: 29148156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA
    Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China.
    Wang S; Luo M; Sun H; Song Y; Yin C; Wang L; Hui R; Hu S
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):534-40. PubMed ID: 22761504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?
    Riedlbauchová L; Janoušek J; Veselka J
    J Invasive Cardiol; 2013 Jun; 25(6):E128-32. PubMed ID: 23735367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.
    Guo HC; Li JH; Jiang TY; Ren CW; Dai J; Zhou YJ; Lai YQ
    Chin Med J (Engl); 2018 Mar; 131(5):527-531. PubMed ID: 29483385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical septal myectomy for hypertrophic cardiomyopathy in Greece: a single-center initial experience.
    Efthimiadis GK; Pitsis A; Pagourelias ED; Kamperidis V; Kelpis T; Meditskou S; Hadjimiltiades S; Ninios V; Mezilis N; Maron BJ; Styliadis IH
    Hellenic J Cardiol; 2014; 55(2):132-8. PubMed ID: 24681791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
    Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
    Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.